Ikarovek is working on early stage assets intended for the treatment of diabetic macular edama.
Ikarovec has raised $10.3M in total funding. The most recent round was Seed. The last funding was announced in October 2024.
Ikarovec's investors include Future Planet Capital, LifeArc, Parkwalk Advisors, LifeArc Ventures, UK Innovation & Science Seed Fund.
Ikarovec is headquartered in Cambridge, United Kingdom.
Ikarovek is working on early stage assets intended for the treatment of diabetic macular edama.
Ikarovec is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ikarovec — Funding & Investors." VCBacked, October 23, 2024, https://www.vcbacked.co/company/ikarovec. Accessed July 22, 2026.
VCBacked. (2024). Ikarovec — Funding & Investors. Retrieved July 22, 2026, from https://www.vcbacked.co/company/ikarovec
{{cite web |title=Ikarovec — Funding & Investors |url=https://www.vcbacked.co/company/ikarovec |website=VCBacked |access-date=July 22, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated